Τόμος 15 (2001) – Τεύχος 3 – Άρθρο 12 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 15 (2001) – Issue 3 – Article 12 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Title Osteoporosis and phytoestrogens – studies in Greece
Author Ismene Dontas

Laboratory for the Research of the Musculoskeletal System Th. Garofalidis, School of Medicine, University of Athens, Athens, Greece

Citation Dontas, I.: Osteoporosis and phytoestrogens – studies in Greece, Epitheorese Klin. Farmakol. Farmakokinet. 15(3): 161-162 (2001)
Publication Date Accepted for publication: 1 August 2001
Full Text Language English
Order – Buy  Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €) 

pharmakonpress[at]pharmakonpress[.]gr

Keywords Osteoporosis, hormone replacement therapy, oestrogen, phytoestrogen, bone mass.
Other Terms review article
Summary Among the major health problems of the world’s aging society is osteoporosis and its treatment. An ideal therapeutic approach improves the patient’s quality of life and solves the medical and socio-economic problems involved. However, when hormone replacement therapy is advised for high bone turnover postmenopausal women, usually few patients show good compliance. Alternative strategies are therefore being investigated. Phytoestrogens have been the object of recent studies due to their mild oestrogenic effect and their possible potential role in osteoporosis prevention and/or treatment. A preliminary study of the oestrogenic effect of a Greek plant’s extract on the rat ovariectomy experimental model of osteoporosis is presented.
References 1.    Kanis JA, Delmas P, Burkhardt P, Cooper C, Torgerson D. Guidelines for diagnosis and management of osteoporosis. Osteoporos Int 7: 390-406 (1997)

2.    Cooper C, Atkinson EJ, Jacobsen SJ, O’Falion WM, Melton LJ. Population-based study of survival after osteoporotic fractures. Amer J Epidemiol 137: 1001-5 (1993)

3.    Cooper C, Campion G, Melton LJ. Hip fractures in the elderly. A world-wide projection. Osteoporos Int 2: 285-289 (2000)

4.    Cumming Ft and Nevitt M. Calcium for prevention of osteoporotic fractures in postmenopausal women. J Bone Miner Res 12: 1321-9(1997)

5.    Recker R, Hinders S, Davies KM, Heaney RP, Stegman MR, Lappe JM, Kimmel DB. Correcting calcium nutritional deficiency prevents spine fractures in elderly women. J Bone Miner Res 11: 1961-6 (1996)

6.    Johnson RE and Specht EE. The risk of hip fracture in post-menopausal females with and without oestrogen exposure. Am J Pub) Health 71: 139-144 (1981)

7.    Lufkin EG, Wahner HW, O’Fallon WM, Hodgson SF, Kotowisz MA, Lane AW, Judd HL, Caplan RH, Riggs BL. Treatment of postmenopausal osteoporosis with transdermal oestrogen. Ann intern Med 117: 1-9 (1992)

8.    Bryant HU and Dere WH. Selective estrogen receptor modulators: an alternative to hormone replacement therapy. Proc Soc Exp Biol Med 217: 45-52 (1998)

9.    Coxam V. Phytoestrogens and osteoporosis: animal studies. Ann Nutr Metab 45: 221 (abstract) (2001)

10.  Potter SM, Baun JA, Teng H, Stillman RJ, Shay NF, Erdman JW. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 68: 1375-9(1998)

11.  Picherit C, Bennetau-Pelissero C, Chanteranne B, Lebecque P, Davicco MJ, Barlet JP, Coxam V. Soybean isoflavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats. J Nutr 131: 723-8(2001).

12.  Picherit C, Coxam V, Bennetau-Pelissero C, Kati-Coulibaiy S, Davicco MJ, Lebecque P, Barlet JP. Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. J Nutr 130: 1675-81 (2000).

13.  Jee WSS, Yao W. Overview: animal models of osteopenia and osteoporosis. J Musculoskel Neuron Interact 1: 193-207 (2001).

Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς – 
What is Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – 
Articles Published in Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2001 – ANNUAL SUBSCRIPTION 2001
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)

pharmakonpress[at]pharmakonpress[.]gr

Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)

pharmakonpress[at]pharmakonpress[.]gr

 

 

 

 

Bookmark the permalink.

Comments are closed.